Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

520.39 -17.90 (-3.33%)
Streaming Delayed Price Updated: 2:13 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Why Shares of Point Biopharma Global Are Soaring Tuesday
The company entered into a buyout agreement with Eli Lilly. 
Via The Motley Fool
Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration
All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration  
Via Benzinga
Nasdaq Down Over 200 Points; US Job Openings Rise In August
U.S. stocks extended losses midway through trading, with the Nasdaq Composite falling more than 200 points on Tuesday. The Dow traded down 1.06% to 33,078.27 while the NASDAQ fell 1.60% to 13,094.83.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Point Biopharma Stock Nearly Doubles On Eli Lilly Deal
Eli Lilly is spending $1.4 billion on buying Point Biopharma Global Inc. Point Biopharma is a radiopharmaceutical company focused on cancer treatment. 
Via Talk Markets
S&P 500 Forecast: Stocks Drop As Treasury Yields Surge
US stocks are heading lower as US treasury yields surge to a 16 year high. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Analyst Ratings for Eli Lilly
Via Benzinga
FDA Declines To Approve Eli Lilly's Eczema Drug
The U.S. 
Via Benzinga
Exposures Product Safety
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company. 
Via Benzinga
'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories
Benzinga 
Via Benzinga
Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Vericity, Inc. (NASDAQ: VERY) shares climbed... 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Falls Over 100 Points; McCormick Sales Miss Views
U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.37% to 33,310.99 while the NASDAQ fell... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Point Biopharma Stock Launches 84% On Eli Lilly's $1.4 Billion Takeover
The company is working on targeted radiation therapy with prostate cancer results up next. 
Via Investor's Business Daily
Why Is Cancer Treatment Focused POINT Biopharma Stock Trading Higher Today?
Eli Lilly And Co (NYSE: LLY) agreed to acquire POINT Biopharma Global Inc (NASDAQ: PNT) at $12.50 per share in cash, an aggregate of  
Via Benzinga
Why Cancer-Focused ALX Oncology Stock Gained Over 100% Today?
ALX Oncology Holdings Inc (NASDAQ: ALXO) released prespecified interim Phase 2 data from its ASPEN-06 trial of evorpacept plus trastuzumab, Cyramza (ramucirumab) and paclitaxel for HER2-positive... 
Via Benzinga
Why Is Point Biopharma (PNT) Stock Up 84% Today?
Point Biopharma stock is heading higher on Tuesday as investors react to news of Eli Lilly acquiring the shares of PNT for $12.50 each. 
Via InvestorPlace
Meet Soleno Therapeutics, The Company Whose Hunger Suppressant Sent Shares Flying 505%
Soleno Therapeutics is working on a treatment for Prader Willi syndrome, a genetic disease that causes obesity. 
Via Investor's Business Daily
Why Shares of Structure Therapeutics Are Up Monday
The stock climbed for the second straight day after the company reported positive trial data for its weight-loss therapy drug. 
Via The Motley Fool
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
The stars are aligning for these pharmaceutical giants, making their stocks look ready to run higher in next year. 
Via InvestorPlace
Stable Giants: 3 Bigwig Biotech Stocks for Consistent Returns
These biotech stocks, Thermo Fisher, Novo Nordisk, and Eli Lilly, will bring consistent returns in the volatile biotech sector. 
Via InvestorPlace
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
These defensive index funds can help investors hedge against a possible recession. 
Via The Motley Fool
What A Government Shutdown Could Mean For You
In a nail-biting development amid fears of a government shutdown, the House has passed a bipartisan bill, narrowly averting the blackout as the midnight deadline looms. 
Via Benzinga
These 5 Stocks Are Setting Up This Buying Opportunity After Strong Runs
Stocks can offer a new buying opportunity with a pullback to the 50-day line. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Shares of Structure Therapeutics Are Soaring on Friday
The company reported positive results from an early-stage clinical trial for its weight-loss therapy candidate. 
Via The Motley Fool
Newcomer Structure Throws Down The Gauntlet In Obesity Treatment -- Shares Soar 66%
The company is working on a pill to help weight loss, rivaling shots from Novo and, possibly, Lilly. 
Via Investor's Business Daily
Eli Lilly, Former Employee Settle Lawsuit Concerning Manufacturing Dispute
Eli Lilly And Co (NYSE: LLY) has settled a lawsuit filed by a former employee, Amrit Mula, who alleged that she was wrongfully terminated after raising concerns about manufacturing practices and data... 
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
Abbott and Dexcom stocks have tumbled as GLP-1 drugs have gripped the nation. 
Via Investor's Business Daily
After Achieving 100% Cancer Remission Rates In Preclinical Studies, Starpax Magnetodrones Head For Human Trials
--News Direct-- 
Via News Direct
Topics Death
Exposures Death
3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals
The demand for biotech stocks is intense and is likely to only greatly increase going forward, especially in the United States. 
Via InvestorPlace
Despite Being Costly, Ozempic, Wegovy Prescriptions Surge 300% Over Three Years
An analytics firm Trilliant Health analysis revealed a significant surge in prescriptions for diabetes and obesity drugs like Ozempic and Wegovy during the 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
48 49 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.